Ashurst advised Jefferies, as sole bookrunner, in relation to an accelerated book build private placement of new shares by Kiadis Pharma N.V., a clinical stage biopharmaceutical…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
